Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-530-4 | CAS number: 129423-54-7 PV-ECHTGELB HGR
Substance identity
Identification
- Display Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
Type of Substance
- Composition:
- mono-constituent substance
- Origin:
- organic
Substance Identifiers open all close all
Compositions
Boundary Composition(s) open all close all
Nanoform
| Nanoform |
- State Form:
- solid: nanoform
Characterisation of nanoforms
- Type of information reported:
- single nanoform
- Name of nanoform:
- C.I. Pigment Yellow 191 - joint submission
Shape
Shape descriptionopen allclose all
- Shape category:
- spheroidal
- Remarks:
- multimodal shapes containing > 70 - < 100 % spheroidal particles and > 0 - < 30 % elongated particles
- Shape:
- cubic
- Pure shape:
- no
- Range:
- > 70 - < 100 %
- Shape category:
- spheroidal
- Remarks:
- multimodal shapes containing > 70 - < 100 % spheroidal particles and > 0 - < 30 % elongated particles
- Shape:
- spherical
- Pure shape:
- no
- Range:
- > 0 - < 30 %
- Shape category:
- elongated
- Remarks:
- multimodal shapes containing > 70 - < 100 % spheroidal particles and > 0 - < 30 % elongated particles
- Shape:
- rod
- Pure shape:
- yes
- Range:
- > 0 - < 30 %
Particle size distribution and range
Particle size distribution and rangeopen allclose all
- Shape category:
- spheroidal
- Remarks:
- multimodal shapes containing > 70 - < 100 % spheroidal particles and > 0 - < 30 % elongated particles
Percentileopen allclose all
- Percentile:
- D10
- Range:
- >= 0.01 - <= 0.04 μm
- Percentile:
- D50
- Range:
- >= 0.015 - <= 0.075 μm
- Percentile:
- D90
- Range:
- >= 0.03 - <= 0.11 μm
- Fraction of constituent particles in the size range 1-100 nm:
- >= 80 - <= 100 %
- Shape category:
- elongated
- Remarks:
- multimodal shapes containing > 70 - < 100 % spheroidal particles and > 0 - < 30 % elongated particles
Percentileopen allclose all
- Percentile:
- D10
- Range:
- >= 0.01 - <= 0.04 μm
- Percentile:
- D50
- Range:
- >= 0.015 - <= 0.075 μm
- Percentile:
- D90
- Range:
- >= 0.03 - <= 0.11 μm
- Range of length:
- >= 0.055 - <= 0.3 μm
- Range of aspect ratio (:1):
- >= 3 - <= 4.9
- Fraction of constituent particles in the size range 1-100 nm:
- >= 80 - <= 100 %
Crystallinity
Structures
- Structure:
- crystalline
- Name:
- C.I. Pigment Yellow 191
- Pure structure:
- yes
Specific surface area
- Range of specific surface area:
- >= 5 - <= 125 m²/g
Surface functionalisation / treatment
- Surface treatment applied:
- no
Legal Entity Composition(s) open all close all
Nanoform
| Nanoform |
- State Form:
- solid: nanoform
Characterisation of nanoforms
- Type of information reported:
- single nanoform
- Name of nanoform:
- C.I. Pigment Yellow 191 - joint submission
Shape
Shape descriptionopen allclose all
- Shape category:
- spheroidal
- Remarks:
- multimodal shapes containing > 75 - < 100 % spheroidal particles and > 0 - < 25 % elongated particles
- Shape:
- cubic
- Pure shape:
- no
- Range:
- > 70 - < 100 %
- Shape category:
- spheroidal
- Remarks:
- multimodal shapes containing > 75 - < 100 % spheroidal particles and > 0 - < 25 % elongated particles
- Shape:
- spherical
- Pure shape:
- no
- Range:
- > 0 - < 30 %
- Shape category:
- elongated
- Remarks:
- multimodal shapes containing > 75 - < 100 % spheroidal particles and > 0 - < 25 % elongated particles
- Shape:
- rod
- Pure shape:
- yes
- Range:
- > 0 - < 25 %
Particle size distribution and range
Particle size distribution and rangeopen allclose all
- Shape category:
- spheroidal
- Remarks:
- multimodal shapes containing > 75 - < 100 % spheroidal particles and > 0 - < 25 % elongated particles
Percentileopen allclose all
- Percentile:
- D10
- Range:
- >= 0.015 - <= 0.035 μm
- Percentile:
- D50
- Range:
- >= 0.025 - <= 0.065 μm
- Percentile:
- D90
- Range:
- >= 0.045 - <= 0.105 μm
- Fraction of constituent particles in the size range 1-100 nm:
- >= 80 - <= 100 %
- Shape category:
- elongated
- Remarks:
- multimodal shapes containing > 75 - < 100 % spheroidal particles and > 0 - < 25 % elongated particles
Percentileopen allclose all
- Percentile:
- D10
- Range:
- >= 0.015 - <= 0.035 μm
- Percentile:
- D50
- Range:
- >= 0.025 - <= 0.065 μm
- Percentile:
- D90
- Range:
- >= 0.045 - <= 0.105 μm
- Range of length:
- >= 0.085 - <= 0.265 μm
- Range of aspect ratio (:1):
- >= 3 - <= 4.7
- Additional information:
- The determined particle size distribution relates to both shape categories. Due to the low number of elongated particles no spearate evaluation for rods had been conducted. The smallest dimension of all particles had been considered
- Fraction of constituent particles in the size range 1-100 nm:
- >= 80 - <= 100 %
Crystallinity
Structures
- Structure:
- crystalline
- Name:
- C.I. Pigment Yellow 191
- Pure structure:
- yes
Specific surface area
- Range of specific surface area:
- >= 20 - <= 40 m²/g
- Skeletal density:
- 1.673 g/cm³
Surface functionalisation / treatment
- Surface treatment applied:
- no
- State Form:
- solid: particulate/powder
Constituent 1
- Reference substance name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
- State Form:
- solid: particulate/powder
Constituent 1
- Reference substance name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
- State Form:
- solid: particulate/powder
Constituent 1
- Reference substance name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
- State Form:
- solid: particulate/powder
Constituent 1
- Reference substance name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
- State Form:
- solid: particulate/powder
Constituent 1
- Reference substance name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
Constituent 1
- Reference substance name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
Constituent 1
- Reference substance name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- EC Number:
- 403-530-4
- EC Name:
- Calcium 4-chloro-2-(5-hydroxy-3-methyl-1-(3-sulfonatophenyl)pyrazol-4-ylazo)-5-methylbenzenesulfonate
- CAS Number:
- 129423-54-7
- Molecular formula:
- C17H13CaClN4O7S2
- IUPAC Name:
- calcium 4-chloro-5-methyl-2-{2-[3-methyl-5-oxo-1-(3-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-4-yl]diazen-1-yl}benzene-1-sulfonate
Composition(s) generated upon use
Other types of composition(s)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
